Rafael Bejar, Ph.D.

Affiliations: 
2001 University of California, San Diego, La Jolla, CA 
Area:
Memory
Google:
"Rafael Bejar"
Mean distance: 13.61 (cluster 29)
 
SNBCP

Parents

Sign in to add mentor
Larry R. Squire grad student 2001 UCSD
 (Genetic manipulations of synaptic plasticity, learning, and memory: Findings from calcium/calmodulin-dependent protein kinase II and K(v)4.2 transgenic mice.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bernard E, Hasserjian RP, Greenberg PL, et al. (2024) Molecular Taxonomy of Myelodysplastic Syndromes and its Clinical Implications. Blood
Sirenko M, Bernard E, Creignou M, et al. (2024) Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes. Blood
DeZern AE, Goll JB, Lindsley RC, et al. (2023) Utility of Targeted Gene Sequencing to Differentiate Myeloid Malignancies from other Cytopenic Conditions. Blood Advances
Bernard E, Tuechler H, Greenberg PL, et al. (2022) Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. Nejm Evidence. 1: EVIDoa2200008
Huang YJ, Chen JY, Yan M, et al. (2022) RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS. Blood Advances
Bernard E, Nannya Y, Hasserjian RP, et al. (2020) Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nature Medicine
Malcovati L, Stevenson K, Papaemmanuil E, et al. (2020) SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM). Blood
Park SJ, Bejar R. (2020) Clonal Hematopoiesis in Cancer. Experimental Hematology
Pine AB, Chokr N, Stahl M, et al. (2020) Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey. Leukemia & Lymphoma. 1-10
Bejar R. (2019) Advances in Personalized Therapeutic Approaches in Myelodysplastic Syndromes. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 1444-1447
See more...